Inhibikase Therapeutics, Inc. | Warrant Agreements | Business Contracts

Form of Private Common Warrant (Filed With SEC on January 26, 2023)

Form of Pre-Funded Warrant (Filed With SEC on January 26, 2023)

Form of PIPE Pre-Funded Warrant (Filed With SEC on January 26, 2023)

Form of PIPE Common Warrant (Filed With SEC on January 26, 2023)

Form of Placement Agent Warrant (Filed With SEC on January 26, 2023)

Form of Representatives Warrant Agreement (Filed With SEC on June 16, 2021)

Form of Representatives Warrant (Filed With SEC on June 11, 2021)

Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated January 1, 2019 (Filed With SEC on September 15, 2020)

Warrant, issued by Inhibikase Therapeutics, Inc. to Flagship Consulting, Inc., dated August 25, 2020 (Filed With SEC on September 15, 2020)

Form of Warrant to purchase common stock of the Registrant, issued to each of the investors named in Schedule A thereto (Filed With SEC on July 23, 2020)

Warrant dated October 5, 2018, issued by Inhibikase Therapeutics, Inc. to Kubera North America, Inc (Filed With SEC on July 23, 2020)

Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated January 1, 2020 (Filed With SEC on July 23, 2020)

Warrant, issued by Inhibikase Therapeutics, Inc. to Francis E. McDaniel, dated March 31, 2020 (Filed With SEC on July 23, 2020)

Form of Representatives Warrant (Filed With SEC on July 23, 2020)

Form of Late IPO Warrant (Filed With SEC on July 23, 2020)

Inhibikase Therapeutics, Inc. (58) | Warrant Agreements (16)